Annual distribution of IG-ralated AE reports. by Shaozhi Liu (13720340)

“…In pregnant women, hypoglycaemia (IC025 = 4.25) was detected as a strong signal, hypoglycaemia neonatal (IC025 = 2.96) as a medium signal, while ketoacidosis (IC025 = 0.76), decreased insulin requirement (IC025 = 0.24), and underweight (IC025 = 0.09) were identified as weak signals. …”

Proportion of AEs by SOCs in pregnant women. by Shaozhi Liu (13720340)

“…In pregnant women, hypoglycaemia (IC025 = 4.25) was detected as a strong signal, hypoglycaemia neonatal (IC025 = 2.96) as a medium signal, while ketoacidosis (IC025 = 0.76), decreased insulin requirement (IC025 = 0.24), and underweight (IC025 = 0.09) were identified as weak signals. …”

Image_1_Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients.TIF by Yanting Zhang (338754)

“…</p><p>Results: Compared with controls, 2D-RVFWLS and 3D-RVEF were both significantly decreased in COVID-19 patients (−27.2 ± 4.4% vs. −22.9 ± 4.8%, P < 0.001; 53.7 ± 4.5% vs. 48.5 ± 5.8%, P < 0.001). …”

Presentation_1_Prognostic Value of Right Ventricular Ejection Fraction Assessed by 3D Echocardiography in COVID-19 Patients.pdf by Yanting Zhang (338754)

“…</p><p>Results: Compared with controls, 2D-RVFWLS and 3D-RVEF were both significantly decreased in COVID-19 patients (−27.2 ± 4.4% vs. −22.9 ± 4.8%, P < 0.001; 53.7 ± 4.5% vs. 48.5 ± 5.8%, P < 0.001). …”

Table_9_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_7_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_10_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_6_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_3_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_4_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_2_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_1_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

Table_8_Regulatory SVA retrotransposons and classical HLA genotyped-transcripts associated with Parkinson’s disease.xlsx by Jerzy K. Kulski (3229236)

“…Only the expressed HLA-DRA*01:01:01 and -DQA1*03:01:01 protective alleles (PD v HC), the -DQA1*03:03:01 risk (HC v Prodrome) or protective allele (PD v Prodrome), the -DRA*01:01:02 and -DRB4*01:03:02 risk alleles (SWEDD v HC), and the NR_SVA_381 present genotype (PD v HC) at a 5% homozygous insertion frequency near HLA-DPA1, were significant (Pc<0.1) after Bonferroni corrections. …”

GlVps depletion affects AcPh localization and activity. by Maria R. Rivero (141332)

“…Relative molecular weights of protein standards (kDa) are indicated on the left. (D) AcPh-V5 is mislocalized in <i>GlVps-antisense+AcPh-V5</i> (AS) transgenic trophozoites compared with control <i>AcPh-V5</i> transgenic trophozoites (Ctrol).…”

Essential role of Sema4D in estrogen-mediated vaginal apoptosis. by Takuji Ito (566032)

“…OVX-oil treatment of WT mice significantly decreases apoptotic cell number in 5-week-old vaginal epithelia relative to that in Sham; compared with OVX-oil treatment, OVX-E2 treatment of WT mice induces a significant increase in apoptotic cell number in 5-week-old vaginal epithelia, comparable to the level of Sham. …”

Figure S1 - Synergistic and Additive Effects of Epigallocatechin Gallate and Digitonin on <em>Plasmodium</em> Sporozoite Survival and Motility by Janina K. Hellmann (254805)

“…However, decreasing the BSA concentration further resulted in a drastic reduction of gliding parasites. …”

Soybean tolerance to defoliation at the beginning of pod formation as affected by plant density by Murilo Miguel Durli (4703707)

“…The experimental design was a randomized block in a split-plot arrangement. …”

IP3Rs localization and function. by Ilanit Itzhaki (225708)

“…(<b>E–F</b>) Dose-response curves displaying the effects of 2-APB (0.1, 0.5, 1, 2, 5 and 10 µM) (E) and U73122 (0.5, 1, 2 and 3 µM) (F) on whole-cell [Ca²⁺]_i transients amplitude (displayed as the relative decrease (%) versus baseline values). …”

Force transients during length changes in different Ca²⁺ concentrations. by Fabio C. Minozzo (189129)

“…(B) Superimposed contractions showing the force decrease during shortening when a fibre was activated in pCa²⁺4.5 (solid line) and pCa²⁺6.0 (dashed line) (top), with the corresponding length changes (bottom). …”

Effects of tPA and cilostazol on endothelial cells at 18 h after reperfusion. by Mitsunori Ishiguro (359127)

“…Western blot analysis measured the levels of claudin-5. tPA alone at 6 h decreased claudin-5 levels. …”